Drug recall D-0349-2019
Product
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40
Reason for recall
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Lots and codes
Lot: 17180918, EXP June 2020
Recall details
- Recalling firm
- Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ
- Quantity
- 5,016 blister packs
- Distribution
- Nationwide
- Type
- Voluntary: Firm initiated
- Recall initiated
- November 27, 2018
- Terminated
- September 12, 2019
Related products
- Aprepitant – drug information
- NDC 68462-585 Aprepitant · Aprepitant 125 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-583 Aprepitant · Aprepitant 40 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-584 Aprepitant · Aprepitant 80 mg/1 · Glenmark Pharmaceuticals Inc., USA
- NDC 68462-112 Aprepitant · · Glenmark Pharmaceuticals Inc., USA